Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-11

FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Cosette Pharmaceuticals' generic Calcipotriene and Betamethone Dipropionate combination for the treatment of plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene and Betamethasone Dipropionate (Calcipotriene and Betamethasone Dipropionate)

Snippet

ORIG AP for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)